NFL has shown consistent utility as a biomarker of active neuroinflammation, future brain atrophy and immunosuppressive treatment response in PMS at a group level, and shows promising results as a disease intensity marker in non-inflammatory neurodegenerative diseases. The gene discussed is NEFL; the disease is Brain atrophy.